KDOQI (Kidney Disease Outcomes Quality Initiative)
NKF KDOQI GUIDELINES

Executive Summaries | Anemia | Hemodialysis | Peritoneal Dialysis |
Vascular Access | Nutrition | CKD 2002 | Dyslipidemias | Bone Metabolism | Hypertension and Antihypertensive Agents | Cardiovascular Disease in Dialysis Patients | History of KDOQI | Pediatric Bone | Anemia 2006 |
Updates 2006

Clinical Practice Guidelines and Clinical Practice Recommendations
2006 Updates
Hemodialysis Adequacy
Peritoneal Dialysis Adequacy
Vascular Access


I. CLINICAL PRACTICE GUIDELINES FOR VASCULAR ACCESS

Acronyms and Abbreviations

aOR
Adjusted odds ratio
AMI
Acute myocardial infarction
AUC
Area under the curve
AV
Arteriovenous
AVF
Arteriovenous fistula
AVG
Arteriovenous graft
BFR
Blood flow rate
BP
Blood pressure
BTM
Body Thermal Monitor
CDC
Centers for Disease Control and Prevention
CHF
Congestive heart failure
CI
Confidence interval
CKD
Chronic kidney disease
CLS
Catheter lock solution
CMS
Centers for Medicare & Medicaid Services
CPG
Clinical Practice Guideline
CPM
Clinical performance measure
CPR
Clinical Practice Recommendation
CQI
Continuous quality improvement
CRB
Catheter-related bacteremia
CrCl
Creatinine clearance
CVC
Central venous catheter
CVD
Cardiovascular disease
DD
In line dialysance
DDU
Duplex Doppler ultrasound
DOPPS
Dialysis Outcomes and Practice Patterns Study
DOQI
Dialysis Outcomes Quality Initiative
DRIL
Distal revascularization—interval ligation
DSA
Digital subtraction angiography
DU
Doppler ultrasound
DVP
Dynamic venous pressures
FDA
Food and Drug Administration
FFBI
Fistula First Breakthrough Initiative
GFR
Glomerular filtration rate
GPT
Glucose pump infusion technique
Hct
Hematocrit
HD
Hemodialysis
HDM
Hemodynamic monitoring
HTN
Hypertension
IAP
Intra-access pressure
IgG
Immunoglobulin G
KLS
Kidney Learning System
KRT
Kidney replacement therapy
LVH
Left ventricular hypertrophy
MAP
Mean arterial (blood) pressure
MRA
Magnetic resonance angiography
N
Number of subjects
NCC
Noncuffed catheter
nd
No data reported
NKF
National Kidney Foundation
NS
Not significant
NVAII
National Vascular Access Improvement Initiative
OABF
Optodilution by ultrafiltration
ORX
Optodilutional recirculation measurement technique
∆P
Pressure gradient
PAVA
Proximal arteriovenous anastomosis
PD
Peritoneal dialysis
PE
Pulmonary embolism
PFSS
Percutaneous fibrin sheath stripping
PIA
Intra-access pressure
PICC
Peripherally inserted central catheter
PSV
Peak systolic velocity
PTA
Percutaneous angioplasty
PTFE
Polytetrafluoroethylene
PU
Polyurethane
PVD
Peripheral vascular disease
QA
Access blood flow
QA/CQI
Quality assurance/continuous quality improvement
QB
Blood pump flow delivered to the dialyzer
QBP
Blood pump flow
Qf
Ultrafiltration rate
QIP
Quality improvement project
QOL
Quality of life
RCT
Randomized controlled trial
ROC
Receiver operating characteristic
RR
Relative risk
rTPA
Recombinant tissue plasminogen activator
SGA
Subjective global assessment
SVC
Superior vena cava
SVR
Systolic velocity ratio
TCC
Tunneled cuffed catheter
TD
Thermal dilution
tPA
Tissue plasminogen activator
TQA
Transcutaneous optodilution flow method
UDT
Ultrasound dilution technique
UK
Urokinase
UOP
Urine output
UreaD
Urea dialysance
UrCl
Urea clearance
URR
Urea reduction ratio
US
Ultrasonography
USRDS
United States Renal Data System
VAT
Vascular access team
VDP
Venous drip chamber pressure
VFDU
Variable flow Doppler ultrasound